| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 17078 | 2014 |
| Biological, clinical and population relevance of 95 loci for blood lipids TM Teslovich, K Musunuru, AV Smith, AC Edmondson, IM Stylianou, ... Nature 466 (7307), 707-713, 2010 | 4139 | 2010 |
| Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease H Schunkert, IR König, S Kathiresan, MP Reilly, TL Assimes, H Holm, ... Nature genetics 43 (4), 333-338, 2011 | 2256 | 2011 |
| Large-scale association analysis identifies new risk loci for coronary artery disease CARDIoGRAMplusC4D Consortium, P Deloukas, S Kanoni, C Willenborg, ... Nature genetics 45 (1), 25-33, 2013 | 1780 | 2013 |
| New genetic loci link adipose and insulin biology to body fat distribution D Shungin, TW Winkler, DC Croteau-Chonka, T Ferreira, AE Locke, ... Nature 518 (7538), 187-196, 2015 | 1690 | 2015 |
| Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine VP Valkonen, H Päivä, JT Salonen, TA Lakka, T Lehtimäki, J Laakso, ... The Lancet 358 (9299), 2127-2128, 2001 | 806 | 2001 |
| Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol R Laaksonen, K Ekroos, M Sysi-Aho, M Hilvo, T Vihervaara, D Kauhanen, ... European heart journal 37 (25), 1967-1976, 2016 | 586 | 2016 |
| miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study E Raitoharju, LP Lyytikäinen, M Levula, N Oksala, A Mennander, ... Atherosclerosis 219 (1), 211-217, 2011 | 538 | 2011 |
| Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function C Pattaro, A Teumer, M Gorski, AY Chu, M Li, V Mijatovic, M Garnaas, ... Nature communications 7 (1), 10023, 2016 | 516 | 2016 |
| Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants M Dichgans, R Malik, IR König, J Rosand, R Clarke, S Gretarsdottir, ... Stroke 45 (1), 24-36, 2014 | 393 | 2014 |
| High‐dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial H Päivä, KM Thelen, R Van Coster, J Smet, B De Paepe, KM Mattila, ... Clinical Pharmacology & Therapeutics 78 (1), 60-68, 2005 | 387 | 2005 |
| Low-density lipoprotein-independent effects of statins J Davignon, R Laaksonen Current opinion in lipidology 10 (6), 543-560, 1999 | 353 | 1999 |
| Circulating ceramides predict cardiovascular outcomes in the population-based FINRISK 2002 cohort AS Havulinna, M Sysi-Aho, M Hilvo, D Kauhanen, R Hurme, K Ekroos, ... Arteriosclerosis, thrombosis, and vascular biology 36 (12), 2424-2430, 2016 | 320 | 2016 |
| Phenotype standardization for statin‐induced myotoxicity A Alfirevic, D Neely, J Armitage, H Chinoy, RG Cooper, R Laaksonen, ... Clinical Pharmacology & Therapeutics 96 (4), 470-476, 2014 | 252 | 2014 |
| Development and validation of a ceramide-and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients M Hilvo, PJ Meikle, ER Pedersen, GS Tell, I Dhar, H Brenner, B Schöttker, ... European heart journal 41 (3), 371-380, 2020 | 245 | 2020 |
| Molecular Lipids Identify Cardiovascular Risk and Are Efficiently Lowered by Simvastatin and PCSK9 Deficiency K Tarasov, K Ekroos, M Suoniemi, D Kauhanen, T Sylvänne, R Hurme, ... The Journal of Clinical Endocrinology & Metabolism 99 (1), E45-E52, 2014 | 245 | 2014 |
| Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: a genome-wide association meta-analysis involving more than 22 000 cases and … M Preuss, IR König, JR Thompson, J Erdmann, D Absher, TL Assimes, ... Circulation: Cardiovascular Genetics 3 (5), 475-483, 2010 | 244 | 2010 |
| A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle R Laaksonen, M Katajamaa, H Päivä, M Sysi-Aho, L Saarinen, P Junni, ... PloS one 1 (1), e97, 2006 | 235 | 2006 |
| The effect of simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle R Laaksonen, K Jokelainen, J Laakso, T Sahi, M Härkönen, MJ Tikkanen, ... The American journal of cardiology 77 (10), 851-854, 1996 | 234 | 1996 |
| Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short‐term simvastatin treatment in humans R Laaksonen, K Jokelainen, T Sahi, MJ Tikkanen, JJ Himberg Clinical Pharmacology & Therapeutics 57 (1), 62-66, 1995 | 227 | 1995 |